Skip to Content
 

News: Translational Research and Interventional Oncology Research Program

Cancer immunotherapy drugs linked with more serious heart effects

Monday, March 12th, 2018

Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.

VICC study sheds new light on Von Hippel-Lindau syndrome

Monday, March 12th, 2018

A new study by W. Kimryn Rathmell, MD, PhD, and colleagues, reveals a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.

Lovly earns scholarship grant for lung cancer research

Monday, March 12th, 2018

Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer.

Awareness, education goal of new HPV initiative

Monday, March 12th, 2018

Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology, has formed the HPV-Associated Cancer Consortium Vanderbilt (HPVACTIVE) program to raise awareness and provide community-wide education about HPV-associated cancers.

A new target for neuroblastoma

Friday, February 16th, 2018

A new study by Dai Chung, MD, and colleagues reports that a protein, called SIRT6, plays an important role in the growth of neuroblastoma and suggests that SIRT6 may be a target for new therapeutics for the disease.

Lung screening program continues to grow

Thursday, January 11th, 2018

Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.

Rathmell elected to ASCO nominating committee

Tuesday, December 19th, 2017

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee of the American Society of Clinical Oncology (ASCO).

Liquid biopsies help reveal lung cancer mutations

Thursday, November 2nd, 2017

Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC)

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR T therapy

Wednesday, October 25th, 2017

Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma.

Boosting sarcoma cell death

Friday, October 6th, 2017

A recent study by Dai Chung, M.D., and colleagues suggests new therapeutic options for Ewing sarcoma, a type of rare, aggressive childhood cancer.

Next Page »